Tumor targeting of functionalized quantum dot liposome hybrids by intravenous administration

Molecular Pharmaceutics

Volumn 6, Issue 2, 2009, Pages 520-530

  Al Jamal, WafA'T ^a   Al Jamal, Khuloud T ^a   Tian, Bowen ^a   Cakebread, Andrew ^b   Halket, John M ^b   Kostarelos, Kostas ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Biodistribution; Hybrid; ICP MS; Liposomes; Pharmacokinetics; Quantum dots; Tumor targeting

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; 1,2 DISTEAROYLGLYCERO 3 PHOSPHOETHANOLAMINE N (METHOXYMACROGOL 2000); CADMIUM; CARBON 14; CARBOXYFLUORESCEIN; CHOLESTEROL; DIOLEOYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLCHOLINE; FUNCTIONALIZED QUANTUM DOT LIPOSOME HYBRID NANOPARTICLE; LIPOSOME; MACROGOL 2000; QUANTUM DOT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG STABILITY; DRUG STRUCTURE; DRUG TARGETING; FEMALE; LIQUID SCINTILLATION COUNTING; MASS SPECTROMETRY; MELANOMA; MOUSE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; STEREOCHEMISTRY;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; LIPIDS; LIPOSOMES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NANOPARTICLES; POLYETHYLENE GLYCOLS; QUANTUM DOTS; TISSUE DISTRIBUTION;

EID: 64649104312     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp800187d     Document Type: Article

References (39)

1. Dubertret, B.; Skourides, P.; Norris, D. J.; Noireaux, V.; Brivanlou, A. H.; Libchaber, A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 298 (5599), 17591762.
2. Voura, E. B.; Jaiswal, J. K.; Mattoussi, H.; Simon, S. M. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat. Med. 2004, 10 (9), 993-998.
3. Parak, W. J.; Boudreau, R.; Le Gros, M.; Gerion, D.; Zanchet, D.; Micheel, C. M.; Williams, S. C.; Alivisatos, A. P.; Larabell, C. Cell motility and metastatic potential studies based on quantum dot imaging of phagokinetic tracks. Adv. Mater. 2002, 14 (12), 882-885.
4. Alivisatos, A. P.; Gu, W.; Larabell, C. Quantum dots as cellular probes. Annu. Rev. Biomed. Eng. 2005, 7, 55-76.
5. Ballou, B.; Lagerholm, B. C.; Ernst, L. A.; Bruchez, M. P.; Waggoner, A. S. Noninvasive imaging of quantum dots in mice. Bioconjugate Chem. 2004, 15 (1), 79-86.
6. Ballou, B.; Ernst, L. A.; Andreko, S.; Harper, T.; Fitzpatrick, J. A.; Waggoner, A. S.; Bruchez, M. P. Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjugate Chem. 2007, 18 (2), 389-396.
7. Cai, W.; Shin, D. W.; Chen, K.; Gheysens, O.; Cao, Q.; Wang, S. X.; Gambhir, S. S.; Chen, X. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett. 2006, 6 (4), 669-676.
8. Hoshino, A.; Hanaki, K.; Suzuki, K.; Yamamoto, K. Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body. Biochem. Biophys. Res. Commun. 2004, 314 (1), 46-53.
9. Kim, S.; Lim, Y. T.; Soltesz, E. G.; De Grand, A. M.; Lee, J.; Nakayama, A.; Parker, J. A.; Mihaljevic, T.; Laurence, R. G.; Dor, D. M.; Cohn, L. H.; Bawendi, M. G.; Frangioni, J. V. Near- infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 2004, 22 (1), 93-97.
10. Larson, D. R.; Zipfel, W. R.; Williams, R. M.; Clark, S. W.; Bruchez, M. P.; Wise, F. W.; Webb, W. W. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 2003, 300 (5624), 1434-1436.
11. Rieger, S.; Kulkarni, R. P.; Darcy, D.; Fraser, S. E.; Koster, R. W. Quantum dots are powerful multipurpose vital labeling agents in zebrafish embryos. Dev. Dyn. 2005, 234 (3), 670-681.
12. Smith, J. D.; Fisher, G. W.; Waggoner, A. S.; Campbell, P. G. The use of quantum dots for analysis of chick CAM vasculature. Microvasc. Res. 2007, 73 (2), 75-83.
13. Zimmer, J. P.; Kim, S. W.; Ohnishi, S.; Tanaka, E.; Frangioni, J. V.; Bawendi, M. G. Size series of small indium arsenide-zinc selenide core-shell nanocrystals and their application to in vivo imaging. J. Am. Chem. Soc. 2006, 128 (8), 2526-2527.
14. Michalet, X.; Pinaud, F. F.; Bentolila, L. A.; Tsay, J. M.; Doose, S.; Li, J. J.; Sundaresan, G.; Wu, A. M.; Gambhir, S. S.; Weiss, S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307 (5709), 538-544.
15. Fischer, H. C.; Liu, L. C.; Pang, K. S.; Chan, W. C. W. Pharmacokinetics of nanoscale quantum dots: In vivo distribution, sequestration, and clearance in the rat. Adv. Funct. Mater. 2006, 16 (10), 1299-1305.
16. Akerman, M. E.; Chan, W. C.; Laakkonen, P.; Bhatia, S. N.; Ruoslahti, E. Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (20), 12617-12621.
17. Gao, X.; Cui, Y.; Levenson, R. M.; Chung, L. W.; Nie, S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004, 22 (8), 969-976.
18. Yu, X.; Chen, L.; Li, K.; Li, Y.; Xiao, S.; Luo, X.; Liu, J.; Zhou, L.; Deng, Y.; Pang, D.; Wang, Q. Immunofluorescence detection with quantum dot bioconjugates for hepatoma in vivo. J. Biomed. Opt. 2007, 12 (1), 014008.
19. Cai, W.; Chen, K.; Li, Z. B.; Gambhir, S. S.; Chen, X. Dual- function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J. Nucl. Med. 2007, 48 (11), 1862-1870.
20. Diagaradjane, P.; Orenstein-Cardona, J. M.; Colon-Casasnovas, E.; Deorukhkar, A.; Shentu, S.; Kuno, N.; Schwartz, D. L.; Gelovani, J. G.; Krishnan, S. Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin. Cancer Res. 2008, 14 (3), 731-741.
21. Gabizon, A.; Price, D. C.; Huberty, J.; Bresalier, R. S.; Papah- adjopoulos, D. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistri- bution and imaging studies. Cancer Res. 1990, 50 (19), 63716378.
22. Ishida, O.; Maruyama, K.; Sasaki, K.; Iwatsuru, M. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int. J. Pharm. 1999, 190 (1), 49-56.
23. Al-Jamal, W. T.; Al-Jamal, K. T.; Bomans, P. H.; Frederik, P. M.; Kostarelos, K. Functionalized quantum dot-liposome hybrids as multi-modal nanoparticles for cancer. Small 2008, 4 (9), 14061415.
24. Zhang, Y.; Anchordoquy, T. J. The role of lipid charge density in the serum stability of cationic lipid/DNA complexes. Biochim. Biophys. Acta 2004, 1663 (1-2), 143-157.
25. Nicolazzi, C.; Mignet, N.; de la Figuera, N.; Cadet, M.; Ibad, R. T.; Seguin, J.; Scherman, D.; Bessodes, M. Anionic polyeth- yleneglycol lipids added to cationic lipoplexes increase their plasmatic circulation time. J. Controlled Release 2003, 88 (3), 429-443.
26. Senior, J.; Gregoriadis, G. Is half-life of circulating liposomes determined by changes in their permeability. FEBS Lett. 1982, 145 (1), 109-114.
27. Papahadjopoulos, D.; Allen, T. M.; Gabizon, A.; Mayhew, E.; Matthay, K.; Huang, S. K.; Lee, K. D.; Woodle, M. C.; Lasic, D. D.; Redemann, C. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. U.S.A. 1991, 88 (24), 11460-11464.
28. Gabizon, A.; Papahadjopoulos, D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. U.S.A. 1998, 85 (18), 6949-6953.
29. Yang, R. S.; Chang, L. W.; Wu, J. P.; Tsai, M. H.; Wang, H. J.; Kuo, Y. C.; Yeh, T. K.; Yang, C. S.; Lin, P. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ. Health Perspect. 2007, 115 (9), 1339-1343.
30. Choi, H. S.; Liu, W.; Misra, P.; Tanaka, E.; Zimmer, J. P.; Ipe, B. I.; Bawendi, M. G.; Frangioni, J. V. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25 (10), 1165-1170.
31. Ogihara-Umeda, I.; Kojima, S. Increased delivery of gallium-67 to tumors using serum-stable liposomes. J. Nucl. Med. 1988, 29 (4), 516-523.
32. Storm, G.; Roerdink, F. H.; Steerenberg, P. A.; de Jong, W. H.; Crommelin, D. J. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer Res. 1987, 47 (13), 3366-3372.
33. Allen, T. M.; Hansen, C. B.; Demenezes, D. E. L. Pharmacoki- netics of Long-Circulating Liposomes. Adv. Drug Delivery Rev. 1995, 16 (2-3), 267-284.
34. Al-Jamal, W. T.; Al-Jamal, K. T.; Tian, B.; Lacerda, L.; Bomans, P. H.; Frederik, P. M.; Kostarelos, K. Lipid-Quantum Dot (L- QD) bilayer vesicles enhance tumor cell uptake and retention in vitro and in vivo. ACS Nano 2008, 2 (3), 408-418.
35. Senior, J.; Gregoriadis, G. Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci. 1982, 30 (24), 2123-2136.
36. le Masne de Chermont, Q.; Chaneac, C.; Seguin, J.; Pelle, F.; Maitrejean, S.; Jolivet, J. P.; Gourier, D.; Bessodes, M.; Scherman, D. Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (22), 9266-9271.
37. Campbell, R. B.; Fukumura, D.; Brown, E. B.; Mazzola, L. M.; Izumi, Y.; Jain, R. K.; Torchilin, V. P.; Munn, L. L. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res. 2002, 62 (23), 6831-6836.
38. Plassat, V.; Martina, M. S.; Barratt, G.; Menager, C.; Lesieur, S. Sterically stabilized superparamagnetic liposomes for MR imaging and cancer therapy: pharmacokinetics and biodistribution. Int. J. Pharm. 2007, 344 (1-2), 118-127.
39. Washington, C.; King, S. M.; Heenan, R. K. Structure of block copolymers adsorbed to perfluorocarbon emulsions. J. Phys. Chem. 1996, 100 (18), 7603-7609.